Clinical Trials
5 trialsNCT04851119 2026-05-05
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
Phase 1/2 Recruiting
NCT05876923 2026-04-09
The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients
Mayo Clinic
Phase NA Recruiting
NCT06983899 2026-02-06
Exercise Training for the Improvement of Immune Activity and Treatment Outcomes During Immunotherapy for Non-small Cell Lung Cancer, BOOST Trial
Fred Hutchinson Cancer Center
Phase NA Recruiting
NCT05838716 2026-01-15
ViPER
University of Rochester
Phase 3 Recruiting
NCT07044310 2025-07-29
5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss
Mayo Clinic
Phase 2 Recruiting